This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Norepinephrine Dysfunction in Depression

Amit Anand, MD, and Dennis S. Charney, MD

Published: August 30, 2000

Article Abstract

The study of the noradrenergic neurotransmitter system remains one of the cornerstones of depressionresearch. Better understanding of the action of norepinephrine and other catecholamines at thesynaptic and intracellular level holds the potential for providing clues to the etiology of depressionand introduces exciting possibilities for the development of novel medications for the treatment ofdepression. The following review of norepinephrine as it relates to depression will shed light on thecurrent understanding of the noradrenergic system and the role for selective norepinephrine reuptakeinhibitors (selective NRIs) in the treatment of depression.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: